These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9075226)

  • 1. The costs of dialysis treatments for patients with end-stage renal disease in France.
    Jacobs C
    Nephrol Dial Transplant; 1997; 12 Suppl 1():29-32. PubMed ID: 9075226
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 3. [Assessment of costs of health insurance, substitution therapy in chronic renal insufficiency].
    Chanut C; Barnouin F; Benech JM; Bouvier P; Briat C; Hecht M; Pollini J; Soutif C; Toselli A
    Rev Epidemiol Sante Publique; 1991; 39(4):353-64. PubMed ID: 1754701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can end-stage renal disease be delayed?
    Naper J
    Hosp Technol Ser; 1994 Dec; 13(15):5-7. PubMed ID: 10139506
    [No Abstract]   [Full Text] [Related]  

  • 5. End-stage renal diseases in patients 75 and over: a new medical, socio-economical and ethical challenge.
    Mignon F; Michel C; Viron B; Mentre F; Jaar B
    Eur J Med; 1992 Sep; 1(5):302-7. PubMed ID: 1341612
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal transplantation costs: an economic analysis and comparison with dialysis costs.
    Aranzabal J; Pérdigo L; Mijares J; Villar F
    Transplant Proc; 1991 Oct; 23(5):2574. PubMed ID: 1926487
    [No Abstract]   [Full Text] [Related]  

  • 7. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG
    N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract]   [Full Text] [Related]  

  • 8. Myths and facts in end-stage renal disease treatment.
    Potter DJ
    Ariz Med; 1984 Feb; 41(2):107-8. PubMed ID: 6367713
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cost of dialysis in France].
    Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
    Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of end-stage renal disease in Alabama.
    Melnick S
    Ala J Med Sci; 1983 Oct; 20(4):456-9. PubMed ID: 6359945
    [No Abstract]   [Full Text] [Related]  

  • 12. The costs of dialysis in Canada.
    Prichard SS
    Nephrol Dial Transplant; 1997; 12 Suppl 1():22-4. PubMed ID: 9075224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End stage renal disease--the end of the road.
    Rao M
    Natl Med J India; 1992; 5(5):241-3. PubMed ID: 1302587
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost of clinical dialysis--a historical perspective.
    Attrill E; Johnson HK
    Semin Nephrol; 2000 Nov; 20(6):523-5. PubMed ID: 11111853
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care.
    Manns B; Meltzer D; Taub K; Donaldson C
    Health Econ; 2003 Nov; 12(11):949-58. PubMed ID: 14601157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regular dialysis and kidney transplantation as complementary methods of treatment--medical and economic aspects].
    Zec J; Orlić P; Vujaklija-Stipanović K; Razmilić D; Valencić M; Cohar F; Grzetić M; Matić-Glazar D
    Lijec Vjesn; 1987; 109(11-12):458-60. PubMed ID: 3320650
    [No Abstract]   [Full Text] [Related]  

  • 20. Squeezing the inner-city dialysis dollar.
    Kanter A
    Nephrol News Issues; 1989 Nov; 3(11):24-6. PubMed ID: 2594108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.